VYGR / Voyager Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Voyager Therapeutics, Inc.
US ˙ NasdaqGS ˙ US92915B1061

Deler fremragende 59,599,375 shares
Insideraktier28.488.637 shares
Insider ejerskab47,80 %
Total Insiders37
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

-4 ( )
10379 out of 10945

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

-0.206% ( )
10388 out of 10814

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Voyager Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Julie Burek VP, Finance - [O] 52.458 52.458
Todd Alfred Carter Chief Scientific Officer - [O] 145.718 145.718
Wendy L Dixon 15.000
Allison Dorval Chief Financial Officer - [O] 109.894 109.894
EcoR1 Capital, LLC 10% Owner - [10%] 3.851.507 3.851.507
Sandell Jacquelyn Fahey Chief Legal Officer - [O] 123.143 123.143
Toby Ferguson Chief Medical Officer - [O] 183.914 183.914
James A Geraghty Director - [D] 76.588 76.588
Jeff Goater SVP Finance, Bus. Development - [O] 129.410 129.410
Hadley Harbor Master Investors (Cayman) L.P. 10% Owner - [10%] 470.588 470.588
Jane Henderson Sr. V.P. & CFO, Corp. Dev. - [O] 0 0
Hesslein Robert W. Senior VP & General Counsel - [O] 102.200 102.200
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Michael J Higgins Director - [D] 31.314 31.314
Steven Hyman 15.000
Jorgensen Nathan D. Chief Financial Officer - [O] 151.416 151.416
Perry A Karsen 15.000
Omar Khwaja See remarks - [O] 120.509 120.509
Mark J Levin Director, 10% Owner - [D] [10%] 6.391.176 6.391.176
Neurocrine Biosciences Inc 10% Owner - [10%] 8.575.316 8.575.316
Jude Onyia Director - [D] 5.820 5.820
Ottmer Matthew P. Chief Operating Officer - [O] 26.276 26.276
Steven M Paul President and CEO, Director - [D] [O] 872.351 872.351
Pfreundschuh Peter P. Chief Financial Officer - [O] 175.669 175.669
Glenn Pierce Director - [D] 21.788 21.788
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Bernard Ravina Chief Medical Officer - [O] 0 0
Kevin P Starr 10% Owner - [10%] 6.391.176 6.391.176
Sah Dinah Ph.D. Chief Scientific Officer - [O] 163.688 163.688
Alfred Sandrock President and CEO, Director - [D] [O] 472.549 472.549
Sanofi - 2.477.941 2.477.941
Shiferman Gregory L. SVP and General Counsel - [O] 50.000 50.000
Robin Swartz COO & CBO - [O] 199.738 199.738
Robert I Tepper 10% Owner - [10%] 6.391.176 3.185.291
Trv Gp Iii, Llc 10% Owner - [10%] 6.391.176 3.185.291
Third Rock Ventures GP III, L.P. 10% Owner - [10%] 6.391.176 3.185.291
Third Rock Ventures III, L.P. 10% Owner - [10%] 3.185.291 3.185.291
Andre Turenne President & CEO, Director - [D] [O] 322.375 322.375
Nancy Vitale 30.000

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i VYGR / Voyager Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2023-02-23 NEUROCRINE BIOSCIENCES INC 4.395.588 8,8800 4.395.588 8,8800 39.032.821 117 13.9900 22.461.455 57,55
2022-06-23 EcoR1 Capital, LLC 376.000 5,6557 376.000 5,6557 2.126.543
2022-06-21 EcoR1 Capital, LLC 101.400 5,2811 101.400 5,2811 535.504
2019-03-12 NEUROCRINE BIOSCIENCES INC 4.179.728 11,9625 4.179.728 11,9625 49.999.996
2018-09-12 PIERCE GLENN 5.000 18,4400 5.000 18,4400 92.200
2018-09-10 GERAGHTY JAMES A 3.000 19,3900 3.000 19,3900 58.170
2018-08-17 GERAGHTY JAMES A 3.000 18,3100 3.000 18,3100 54.930
2016-01-14 PAUL STEVEN M 10.000 14,0690 10.000 14,0690 140.690
2015-11-16 Sanofi 125.000 14,0000 125.000 14,0000 1.750.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VYGR / Voyager Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i VYGR / Voyager Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2026-04-02 Sandrock Alfred 11.511 3,8700 11.511 3,8700 44.548 27 3.6400 -2.647 -5,94
2026-02-24 Carter Todd Alfred 4.174 3,7600 4.174 3,7600 15.694
2026-02-24 Sandrock Alfred 14.197 3,7900 14.197 3,7900 53.807
2026-02-24 Jorgensen Nathan D. 4.668 3,7700 4.668 3,7700 17.598
2026-02-24 Swartz Robin 6.458 3,7700 6.458 3,7700 24.347
2026-02-18 Carter Todd Alfred 3.301 3,4400 3.301 3,4400 11.355
2026-02-18 Sandrock Alfred 11.732 3,4100 11.732 3,4100 40.006
2026-02-18 Swartz Robin 3.882 3,4400 3.882 3,4400 13.354
2026-02-10 Sandrock Alfred 12.192 3,7800 12.192 3,7800 46.086

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VYGR / Voyager Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-04-03 2026-04-02 4 Sandrock Alfred VYGR Common Stock S - Sale D 3,8700 -11.511 -45 472.549
2026-04-03 2026-04-01 4 Shiferman Gregory L. VYGR Common Stock A - Award D 50.000 50.000
2026-02-26 2026-02-24 4 Swartz Robin VYGR Common Stock S - Sale D 3,7700 -6.458 -24 199.738
2026-02-26 2026-02-24 4 Jorgensen Nathan D. VYGR Common Stock S - Sale D 3,7700 -4.668 -18 151.416
2026-02-26 2026-02-24 4 Sandrock Alfred VYGR Common Stock S - Sale D 3,7900 -14.197 -54 484.060
2026-02-26 2026-02-24 4 Carter Todd Alfred VYGR Common Stock S - Sale D 3,7600 -4.174 -16 145.718
2026-02-20 2026-02-18 4 Swartz Robin VYGR Common Stock S - Sale D 3,4400 -3.882 -13 206.196
2026-02-20 2026-02-18 4 Carter Todd Alfred VYGR Common Stock S - Sale D 3,4400 -3.301 -11 149.892
2026-02-20 2026-02-18 4 Sandrock Alfred VYGR Common Stock S - Sale D 3,4100 -11.732 -40 498.257
2026-02-11 2026-02-10 4 Swartz Robin VYGR Common Stock S - Sale D 3,8500 -4.569 -18 210.078
2026-02-11 2026-02-10 4 Carter Todd Alfred VYGR Common Stock S - Sale D 3,8500 -3.525 -14 153.193
2026-02-11 2026-02-10 4 Sandrock Alfred VYGR Common Stock S - Sale D 3,7800 -12.192 -46 509.989
2026-02-10 2026-02-06 4 Carter Todd Alfred VYGR Common Stock A - Award D 33.000 156.718
2026-02-10 2026-02-06 4 Ferguson Toby VYGR Common Stock A - Award D 45.000 183.914
2026-02-10 2026-02-06 4 Swartz Robin VYGR Common Stock A - Award D 45.000 214.647
2026-02-10 2026-02-06 4 Sandrock Alfred VYGR Common Stock A - Award D 86.250 522.181
2026-02-10 2026-02-06 4 Jorgensen Nathan D. VYGR Common Stock A - Award D 32.250 156.084
2025-10-07 2025-10-03 4 Jorgensen Nathan D. VYGR Common Stock S - Sale D 4,7800 -7.666 -37 123.834
2025-08-20 2025-08-18 4 Ferguson Toby VYGR Common Stock S - Sale D 3,7300 -19.000 -71 138.914
2025-04-04 2025-04-02 4 Ferguson Toby VYGR Common Stock S - Sale D 3,4300 -10.086 -35 157.914
2025-04-04 2025-04-02 4 Sandrock Alfred VYGR Common Stock S - Sale D 3,4300 -10.885 -37 430.931
2025-02-24 2025-02-21 4 Carter Todd Alfred VYGR Common Stock A - Award D 46.000 123.718
2025-02-24 2025-02-20 4 Carter Todd Alfred VYGR Common Stock S - Sale D 4,2600 -3.305 -14 77.718
2025-02-24 2025-02-21 4 Sandrock Alfred VYGR Common Stock A - Award D 145.000 441.816
2025-02-24 2025-02-20 4 Sandrock Alfred VYGR Common Stock S - Sale D 4,2400 -11.702 -50 296.816
2025-02-24 2025-02-21 4 Swartz Robin VYGR Common Stock A - Award D 71.250 169.647
2025-02-24 2025-02-20 4 Swartz Robin VYGR Common Stock S - Sale D 4,2500 -3.894 -17 98.397
2025-02-24 2025-02-21 4 Fahey Sandell Jacquelyn VYGR Common Stock A - Award D 41.500 123.143
2025-02-24 2025-02-21 4 Ferguson Toby VYGR Common Stock A - Award D 63.000 168.000
2025-02-24 2025-02-21 4 Jorgensen Nathan D. VYGR Common Stock A - Award D 51.500 131.500
2025-02-12 2025-02-11 4 Swartz Robin VYGR Common Stock S - Sale D 4,4500 -6.950 -31 102.291
2025-02-12 2025-02-11 4 Carter Todd Alfred VYGR Common Stock S - Sale D 4,4500 -5.413 -24 81.023
2025-02-12 2025-02-11 4 Sandrock Alfred VYGR Common Stock S - Sale D 4,4500 -16.644 -74 308.518
2025-02-12 2025-02-11 4 Fahey Sandell Jacquelyn VYGR Common Stock S - Sale D 4,4500 -4.358 -19 81.643
2025-01-15 2025-01-14 4 Swartz Robin VYGR Common Stock S - Sale D 5,0900 -3.087 -16 109.241
2025-01-15 2025-01-14 4 Carter Todd Alfred VYGR Common Stock S - Sale D 5,1300 -1.191 -6 86.436
2024-12-26 2024-12-23 4 Swartz Robin VYGR Common Stock S - Sale D 5,6500 -6.500 -37 112.328
2024-10-03 2024-10-02 4 Fahey Sandell Jacquelyn VYGR Common Stock S - Sale D 5,8200 -5.999 -35 86.001
2024-10-02 2024-10-01 4 Jorgensen Nathan D. VYGR Common Stock A - Award D 80.000 80.000
2024-04-03 2024-04-01 4 Ferguson Toby VYGR Common Stock A - Award D 105.000 105.000
2024-04-03 2024-04-02 4 Swartz Robin VYGR Common Stock S - Sale D 9,8800 -1.357 -13 117.004
2024-04-03 2024-04-02 4 Sandrock Alfred VYGR Common Stock S - Sale D 9,8600 -12.115 -119 322.839
2024-02-22 2024-02-21 4 Swartz Robin VYGR Common Stock S - Sale D 7,4500 -3.966 -30 118.361
2024-02-22 2024-02-21 4 Sandrock Alfred VYGR Common Stock S - Sale D 7,4600 -13.033 -97 334.954
2024-02-22 2024-02-21 4 PFREUNDSCHUH PETER P. VYGR Common Stock S - Sale D 7,4600 -3.764 -28 175.669
2024-02-22 2024-02-21 4 Carter Todd Alfred VYGR Common Stock S - Sale D 7,4700 -3.365 -25 87.627
2024-02-22 2024-02-20 4 Carter Todd Alfred VYGR Common Stock S - Sale D 7,6800 -602 -5 90.992
2024-02-16 2024-02-09 4 Fahey Sandell Jacquelyn VYGR Common Stock A - Award D 31.000 92.000
2024-02-16 2024-02-09 4 Carter Todd Alfred VYGR Common Stock A - Award D 38.500 91.594
2024-02-16 2024-02-09 4 Swartz Robin VYGR Common Stock A - Award D 50.000 122.327
2024-02-16 2024-02-09 4 Sandrock Alfred VYGR Common Stock A - Award D 130.000 347.987
2024-02-16 2024-02-09 4 PFREUNDSCHUH PETER P. VYGR Common Stock A - Award D 30.000 179.433
2024-01-19 2024-01-17 4 Swartz Robin VYGR Common Stock S - Sale D 7,1500 -2.543 -18 72.327
2024-01-19 2024-01-17 4 Carter Todd Alfred VYGR Common Stock S - Sale D 7,1800 -1.266 -9 53.094
2023-10-05 2023-10-03 4 PFREUNDSCHUH PETER P. VYGR Common Stock S - Sale D 6,9900 -13.567 -95 149.433
2023-10-02 2023-10-01 4 Fahey Sandell Jacquelyn VYGR Common Stock A - Award D 61.000 61.000
2023-09-18 2023-09-15 4 Carter Todd Alfred VYGR Common Stock S - Sale D 8,1600 -10.500 -86 54.360
2023-09-18 2023-09-15 4 Carter Todd Alfred VYGR Common Stock M - Exercise D 2,8500 5.000 14 64.860
2023-07-10 2023-07-06 4 Carter Todd Alfred VYGR Common Stock S - Sale D 10,8000 -5.500 -59 59.860
2023-07-05 2023-06-30 4 Carter Todd Alfred VYGR Common Stock S - Sale D 11,4100 -5.000 -57 65.360
2023-07-05 2023-06-30 4 Carter Todd Alfred VYGR Common Stock M - Exercise D 2,8500 5.000 14 70.360
2023-04-05 2023-04-03 4 Sandrock Alfred VYGR Common Stock S - Sale D 7,8300 -7.437 -58 214.618
2023-04-05 2023-04-03 4 Swartz Robin VYGR Common Stock S - Sale D 7,8300 -1.259 -10 71.617
2023-03-22 2023-03-20 4 Swartz Robin VYGR Common Stock S - Sale D 7,7600 -3.654 -28 72.876
2023-03-22 2023-03-20 4 Carter Todd Alfred VYGR Common Stock S - Sale D 7,7600 -2.193 -17 65.360
2023-03-22 2023-03-20 4 Hesslein Robert W. VYGR Common Stock S - Sale D 7,7600 -4.410 -34 102.200
2023-03-17 2023-03-15 4 Swartz Robin VYGR Common Stock S - Sale D 8,2000 -15.373 -126 76.530
2023-02-27 3 Onyia Jude VYGR Common Stock D 2.910
2023-02-24 2023-02-23 4 NEUROCRINE BIOSCIENCES INC VYGR Common Stock P - Purchase D 8,8800 4.395.588 39.033 8.575.316
2023-02-22 2023-02-17 4 Sandrock Alfred VYGR Common Stock A - Award D 120.000 222.055
2023-02-22 2023-02-17 4 Hesslein Robert W. VYGR Common Stock S - Sale D 7,4500 -3.297 -25 106.610
2023-02-22 2023-02-17 4 PFREUNDSCHUH PETER P. VYGR Common Stock A - Award D 38.000 163.000
2023-02-22 2023-02-17 4 Swartz Robin VYGR Common Stock A - Award D 40.000 91.903
2023-02-22 2023-02-17 4 Carter Todd Alfred VYGR Common Stock S - Sale D 7,4500 -738 -5 67.553
2023-02-22 2023-02-17 4 Carter Todd Alfred VYGR Common Stock A - Award D 34.000 68.291
2023-02-15 2023-02-13 4 Carter Todd Alfred VYGR Common Stock S - Sale D 7,6700 -797 -6 34.291
2023-02-15 2023-02-13 4 Hesslein Robert W. VYGR Common Stock S - Sale D 7,6700 -2.868 -22 109.907
2023-02-06 2023-02-02 4 Third Rock Ventures III, L.P. VYGR Common Stock J - Other D -1.500.000 3.185.291
2023-02-01 2023-02-01 4 Third Rock Ventures III, L.P. VYGR Common Stock S - Sale D 9,3200 -128.642 -1.199 4.685.291
2023-02-01 2023-01-31 4 Third Rock Ventures III, L.P. VYGR Common Stock S - Sale D 9,2500 -185.000 -1.711 4.813.933
2023-02-01 2023-01-30 4 Third Rock Ventures III, L.P. VYGR Common Stock S - Sale D 9,0300 -75.000 -677 4.998.933
2023-01-31 2023-01-27 4 Third Rock Ventures III, L.P. VYGR Common Stock S - Sale D 9,0200 -50.000 -451 5.073.933
2023-01-26 2023-01-25 4 Third Rock Ventures III, L.P. VYGR Common Stock S - Sale D 9,2200 -50.000 -461 5.123.933
2023-01-26 2023-01-24 4 Third Rock Ventures III, L.P. VYGR Common Stock S - Sale D 9,2700 -100.000 -927 5.173.933
2023-01-24 2023-01-23 4 Third Rock Ventures III, L.P. VYGR Common Stock S - Sale D 9,0600 -55.000 -498 5.273.933
2023-01-24 2023-01-20 4 Third Rock Ventures III, L.P. VYGR Common Stock S - Sale D 9,1500 -100.000 -915 5.328.933
2023-01-19 2023-01-17 4 Carter Todd Alfred VYGR Common Stock S - Sale D 10,3400 -400 -4 35.088
2023-01-19 2023-01-17 4 Carter Todd Alfred VYGR Common Stock S - Sale D 9,5700 -706 -7 35.488
2023-01-19 2023-01-17 4 Swartz Robin VYGR Common Stock S - Sale D 10,3400 -792 -8 51.903
2023-01-19 2023-01-17 4 Swartz Robin VYGR Common Stock S - Sale D 9,5700 -1.396 -13 52.695
2023-01-19 2023-01-17 4 Hesslein Robert W. VYGR Common Stock S - Sale D 10,3400 -792 -8 112.775
2023-01-19 2023-01-17 4 Hesslein Robert W. VYGR Common Stock S - Sale D 9,5700 -1.396 -13 113.567
2023-01-11 2023-01-11 4 EcoR1 Capital, LLC See Note 1 VYGR Common Stock S - Sale I 8,4965 -110.000 -935 3.851.507
2023-01-11 2023-01-10 4 EcoR1 Capital, LLC See Note 1 VYGR Common Stock S - Sale I 8,0542 -336.400 -2.709 3.961.507
2023-01-11 2023-01-09 4 EcoR1 Capital, LLC See Note 1 VYGR Common Stock S - Sale I 7,6717 -456.000 -3.498 4.297.907
2023-01-10 2023-01-06 4 Carter Todd Alfred VYGR Common Stock S - Sale D 6,4100 -388 -2 36.194
2023-01-10 2022-12-31 4 Carter Todd Alfred VYGR Common Stock A - Award D 5,1700 388 2 36.582
2022-10-04 2022-10-01 4 PFREUNDSCHUH PETER P. VYGR Common Stock A - Award D 125.000 125.000
2022-09-21 3 Carter Todd Alfred VYGR Common Stock D 36.194
2022-08-26 2022-08-25 4 Third Rock Ventures III, L.P. VYGR Common Stock S - Sale D 6,2200 -200.000 -1.244 5.428.933
2022-08-26 2022-08-24 4 Third Rock Ventures III, L.P. VYGR Common Stock S - Sale D 6,0900 -149.972 -913 5.628.933
2022-08-18 2022-08-16 4 Third Rock Ventures III, L.P. VYGR Common Stock S - Sale D 6,0400 -128.456 -776 5.778.905
2022-08-16 2022-08-15 4 Third Rock Ventures III, L.P. VYGR Common Stock S - Sale D 6,0400 -135.808 -820 5.907.361
2022-08-16 2022-08-12 4 Third Rock Ventures III, L.P. VYGR Common Stock S - Sale D 6,1200 -348.007 -2.130 6.043.169
2022-07-18 2022-07-14 4 PIERCE GLENN VYGR Common Stock S - Sale D 6,7000 -9.512 -64 16.788
2022-07-18 2022-07-14 4 Higgins Michael J VYGR Common Stock S - Sale D 6,7000 -13.891 -93 31.314
2022-06-23 2022-06-23 4 EcoR1 Capital, LLC See Note 1 VYGR Common Stock P - Purchase I 5,6557 376.000 2.127 4.753.907
2022-06-23 2022-06-21 4 EcoR1 Capital, LLC See Note 1 VYGR Common Stock P - Purchase I 5,2811 101.400 536 4.377.907
2022-04-25 3 EcoR1 Capital, LLC See Notes 1 and 2 VYGR Common Stock I 4.276.507
2022-04-06 2022-04-04 4 Swartz Robin VYGR Common Stock S - Sale D 8,2500 -1.527 -13 52.060
2022-04-06 2022-04-04 4 Hesslein Robert W. VYGR Common Stock S - Sale D 8,2500 -2.786 -23 114.963
2022-03-23 2022-03-21 4 Swartz Robin VYGR Common Stock S - Sale D 8,6800 -51 -0 53.587
2022-03-23 2022-03-21 4 Swartz Robin VYGR Common Stock S - Sale D 8,2900 -4.362 -36 53.638
2022-03-23 2022-03-21 4 Hesslein Robert W. VYGR Common Stock S - Sale D 8,6800 -58 -1 117.749
2022-03-23 2022-03-21 4 Hesslein Robert W. VYGR Common Stock S - Sale D 8,2900 -4.897 -41 117.807
2022-03-23 2022-03-21 4 Burek Julie VYGR Common Stock S - Sale D 8,6800 -31 -0 52.458
2022-03-23 2022-03-21 4 Burek Julie VYGR Common Stock S - Sale D 8,2900 -2.618 -22 52.489
2022-03-23 2022-03-22 4 Sandrock Alfred VYGR Stock Option (Right to Buy) A - Award D 8,55 940.600 940.600
2022-03-23 2022-03-22 4 Sandrock Alfred VYGR Common Stock A - Award D 100.000 100.000
2022-02-22 2022-02-17 4 Hesslein Robert W. VYGR Common Stock S - Sale D 3,5500 -4.100 -15 122.704
2022-02-22 2022-02-17 4 Burek Julie VYGR Common Stock S - Sale D 3,5500 -789 -3 55.107
2022-02-15 2022-02-11 4 Burek Julie VYGR Common Stock S - Sale D 3,3600 -361 -1 55.896
2022-02-15 2022-02-11 4 Hesslein Robert W. VYGR Common Stock S - Sale D 3,3600 -3.252 -11 126.804
2022-02-09 2022-02-07 4 Swartz Robin VYGR Stock Option (Right to Buy) A - Award D 3,32 65.000 65.000
2022-02-09 2022-02-07 4 Sandrock Alfred VYGR Stock Option (Right to Buy) A - Award D 3,32 44.000 44.000
2022-02-09 3 Swartz Robin VYGR Common Stock D 58.000
2022-01-18 2022-01-13 4 Burek Julie VYGR Stock Option (Right to Buy) A - Award D 2,85 40.000 40.000
2022-01-18 2022-01-13 4 Burek Julie VYGR Common Stock A - Award D 10.000 56.257
2022-01-18 2022-01-13 4 Hesslein Robert W. VYGR Stock Option (Right to Buy) A - Award D 2,85 120.000 120.000
2022-01-18 2022-01-13 4 Hesslein Robert W. VYGR Common Stock A - Award D 20.000 130.056
2022-01-18 2022-01-13 4 Higgins Michael J VYGR Stock Option (Right to Buy) A - Award D 2,85 161.000 161.000
2022-01-18 2022-01-13 4 Higgins Michael J VYGR Common Stock A - Award D 45.205 45.205
2022-01-18 2022-01-13 4 PIERCE GLENN VYGR Stock Option (Right to Buy) A - Award D 2,85 50.000 50.000
2022-01-18 2022-01-13 4 PIERCE GLENN VYGR Common Stock A - Award D 26.300 26.300
2022-01-14 2022-01-12 4 Burek Julie VYGR Common Stock S - Sale D 3,0600 -265 -1 46.257
2022-01-14 2022-01-03 4 Burek Julie VYGR Common Stock S - Sale D 2,8300 -3.063 -9 46.522
2022-01-14 2021-12-31 4 Burek Julie VYGR Common Stock A - Award D 2,3000 3.063 7 49.585
2021-11-30 2021-11-26 4 Burek Julie VYGR Stock Option (Right to Buy) A - Award D 3,06 25.000 25.000
2021-11-30 2021-11-26 4 Burek Julie VYGR Common Stock A - Award D 13.500 46.522
2021-11-30 3 Burek Julie VYGR Common Stock D 33.022
2021-06-08 2021-06-07 4 PIERCE GLENN VYGR Stock Option (Right to Buy) A - Award D 4,45 42.000 42.000
2021-06-04 2021-06-03 4 PAUL STEVEN M VYGR Stock Option (Right to Buy) A - Award D 4,23 15.000 15.000
2021-06-04 2021-06-03 4 Vitale Nancy VYGR Stock Option (Right to Buy) A - Award D 4,23 15.000 15.000
2021-06-04 2021-06-03 4 Hyman Steven VYGR Stock Option (Right to Buy) A - Award D 4,23 15.000 15.000
2021-06-04 2021-06-03 4 GERAGHTY JAMES A VYGR Stock Option (Right to Buy) A - Award D 4,23 15.000 15.000
2021-06-04 2021-06-03 4 LEVIN MARK J VYGR Stock Option (Right to Buy) A - Award D 4,23 15.000 15.000
2021-06-04 2021-06-03 4 Higgins Michael J VYGR Stock Option (Right to Buy) A - Award D 4,23 115.000 115.000
2021-06-04 2021-06-03 4 PIERCE GLENN VYGR Stock Option (Right to Buy) A - Award D 4,23 50.000 50.000
2021-05-25 2021-05-21 4 Khwaja Omar VYGR Common Stock S - Sale D 4,0300 -3.516 -14 120.509
2021-04-07 2021-04-05 4 Hesslein Robert W. VYGR Common Stock S - Sale D 4,9500 3.292 16 110.056
2021-03-23 2021-03-19 4 Khwaja Omar VYGR Common Stock A - Award D 35.000 124.025
2021-03-23 2021-03-19 4 Turenne Andre VYGR Common Stock A - Award D 80.000 322.375
2021-03-23 2021-03-19 4 Hesslein Robert W. VYGR Common Stock A - Award D 30.000 113.348
2021-03-23 2021-03-19 4 Dorval Allison VYGR Common Stock A - Award D 30.000 109.894
2021-02-18 2021-02-16 4 Turenne Andre VYGR Stock Option (Right to Buy) A - Award D 7,33 189.000 189.000
2021-02-18 2021-02-16 4 Turenne Andre VYGR Common Stock A - Award D 94.000 242.375
2021-02-18 2021-02-16 4 Khwaja Omar VYGR Stock Option (Right to Buy) A - Award D 7,33 72.000 72.000
2021-02-18 2021-02-16 4 Khwaja Omar VYGR Common Stock A - Award D 36.000 89.025
2021-02-18 2021-02-16 4 Hesslein Robert W. VYGR Stock Option (Right to Buy) A - Award D 7,33 68.000 68.000
2021-02-18 2021-02-16 4 Hesslein Robert W. VYGR Common Stock A - Award D 34.000 83.348
2021-02-18 2021-02-16 4 Dorval Allison VYGR Stock Option (Right to Buy) A - Award D 7,33 68.000 68.000
2021-02-18 2021-02-16 4 Dorval Allison VYGR Common Stock A - Award D 34.000 79.894
2021-02-16 2021-02-11 4 Turenne Andre VYGR Common Stock S - Sale D 7,5500 -7.977 -60 148.375
2021-02-16 2021-02-11 4 Dorval Allison VYGR Common Stock S - Sale D 7,5500 -3.186 -24 45.894
2021-02-16 2021-02-11 4 Hesslein Robert W. VYGR Common Stock S - Sale D 7,5500 -3.186 -24 49.348
2021-02-16 2021-02-11 4 Khwaja Omar VYGR Common Stock S - Sale D 7,5500 -3.475 -26 53.025
2021-01-14 2021-01-12 4 Turenne Andre VYGR Common Stock S - Sale D 8,6200 -10.443 -90 156.352
2021-01-14 2021-01-12 4 Dorval Allison VYGR Common Stock S - Sale D 8,6200 -2.942 -25 49.080
2020-09-16 2020-09-15 4 Vitale Nancy VYGR Stock Option (Right to Buy) A - Award D 10,85 30.000 30.000
2020-06-05 2020-06-04 4 LEVIN MARK J VYGR Stock Option (Right to Buy) A - Award D 11,79 15.000 15.000
2020-06-05 2020-06-04 4 PAUL STEVEN M VYGR Stock Option (Right to Buy) A - Award D 11,79 15.000 15.000
2020-06-05 2020-06-04 4 DIXON WENDY L VYGR Stock Option (Right to Buy) A - Award D 11,79 15.000 15.000
2020-06-05 2020-06-04 4 GERAGHTY JAMES A VYGR Stock Option (Right to Buy) A - Award D 11,79 15.000 15.000
2020-06-05 2020-06-04 4 Hyman Steven VYGR Stock Option (Right to Buy) A - Award D 11,79 15.000 15.000
2020-06-05 2020-06-04 4 Higgins Michael J VYGR Stock Option (Right to Buy) A - Award D 11,79 15.000 15.000
2020-06-05 2020-06-04 4 PIERCE GLENN VYGR Stock Option (Right to Buy) A - Award D 11,79 15.000 15.000
2020-05-22 2020-05-21 4 Khwaja Omar VYGR Common Stock S - Sale D 12,9600 -3.500 -45 56.500
2020-04-07 2020-04-03 4 Hesslein Robert W. VYGR Common Stock S - Sale D 8,5100 -3.091 -26 52.534
2020-02-12 2020-02-10 4 Turenne Andre VYGR Stock Option (Right to Buy) A - Award D 12,96 162.500 162.500
2020-02-12 2020-02-10 4 Turenne Andre VYGR Common Stock A - Award D 81.250 166.795
2020-02-12 2020-02-10 4 Khwaja Omar VYGR Stock Option (Right to Buy) A - Award D 12,96 60.000 60.000
2020-02-12 2020-02-10 4 Khwaja Omar VYGR Common Stock A - Award D 30.000 60.000
2020-02-12 2020-02-10 4 Hesslein Robert W. VYGR Stock Option (Right to Buy) A - Award D 12,96 55.000 55.000
2020-02-12 2020-02-10 4 Hesslein Robert W. VYGR Common Stock A - Award D 27.500 55.625
2020-02-12 2020-02-10 4 Dorval Allison VYGR Stock Option (Right to Buy) A - Award D 12,96 55.000 55.000
2020-02-12 2020-02-10 4 Dorval Allison VYGR Common Stock A - Award D 27.500 52.022
2020-01-29 2020-01-21 4 Turenne Andre VYGR Common Stock S - Sale D 13,3600 -10.705 -143 85.545
2020-01-29 2020-01-21 4 Ottmer Matthew P. VYGR Common Stock S - Sale D 13,3600 -3.724 -50 26.276
2020-01-29 2020-01-21 4 Dorval Allison VYGR Common Stock S - Sale D 13,3600 -3.128 -42 24.522
2019-06-17 2019-06-13 4 DIXON WENDY L VYGR Stock Option (Right to Buy) A - Award D 24,68 15.000 15.000
2019-06-17 2019-06-13 4 Hyman Steven VYGR Stock Option (Right to Buy) A - Award D 24,68 15.000 15.000
2019-06-17 2019-06-13 4 Higgins Michael J VYGR Stock Option (Right to Buy) A - Award D 24,68 15.000 15.000
2019-06-17 2019-06-13 4 LEVIN MARK J VYGR Stock Option (Right to Buy) A - Award D 24,68 15.000 15.000
2019-06-17 2019-06-13 4 GERAGHTY JAMES A VYGR Stock Option (Right to Buy) A - Award D 24,68 15.000 15.000
2019-06-17 2019-06-13 4 PIERCE GLENN VYGR Stock Option (Right to Buy) A - Award D 24,68 15.000 15.000
2019-06-17 2019-06-13 4 KARSEN PERRY A VYGR Stock Option (Right to Buy) A - Award D 24,68 15.000 15.000
2019-06-17 2019-06-13 4 PAUL STEVEN M VYGR Stock Option (Right to Buy) A - Award D 24,68 15.000 15.000
2019-05-22 2019-05-20 4 Khwaja Omar VYGR Stock Option (Right to Buy) A - Award D 21,86 170.000 170.000
2019-05-22 2019-05-20 4 Khwaja Omar VYGR Common Stock A - Award D 30.000 30.000
2019-04-03 2019-04-01 4 Hesslein Robert W. VYGR Stock Option (Right to Buy) A - Award D 19,79 168.750 168.750
2019-04-03 2019-04-01 4 Hesslein Robert W. VYGR Common Stock A - Award D 28.125 28.125
2019-03-14 2019-03-12 4 NEUROCRINE BIOSCIENCES INC VYGR Common Stock P - Purchase D 11,9625 4.179.728 50.000 4.179.728
2019-01-17 2019-01-11 4 Turenne Andre VYGR Stock Option (Right to Buy) A - Award D 9,10 192.500 192.500
2019-01-17 2019-01-11 4 Turenne Andre VYGR Common Stock A - Award D 96.250 96.250
2019-01-17 2019-01-11 4 Sah Dinah Ph.D. VYGR Stock Option (Right to Buy) A - Award D 9,10 50.000 50.000
2019-01-17 2019-01-11 4 Sah Dinah Ph.D. VYGR Common Stock A - Award D 25.000 163.688
2019-01-17 2019-01-11 4 Dorval Allison VYGR Stock Option (Right to Buy) A - Award D 9,10 50.000 50.000
2019-01-17 2019-01-11 4 Dorval Allison VYGR Common Stock A - Award D 25.000 26.106
2019-01-17 2019-01-11 4 Ottmer Matthew P. VYGR Stock Option (Right to Buy) A - Award D 9,10 60.000 60.000
2019-01-17 2019-01-11 4 Ottmer Matthew P. VYGR Common Stock A - Award D 30.000 30.000
2018-11-09 2018-11-07 4 Dorval Allison VYGR Stock Option (Right to Buy) A - Award D 13,99 45.000 45.000
2018-09-19 2018-09-19 4 LEVIN MARK J VYGR Common Stock J - Other I -1.500.000 6.391.176
2018-09-19 2018-09-19 4 Third Rock Ventures III, L.P. VYGR Common Stock J - Other D -1.500.000 6.391.176
2018-09-12 2018-09-12 4 PIERCE GLENN VYGR Common Stock P - Purchase I 18,4400 5.000 92 5.000
2018-09-12 2018-09-10 4 GERAGHTY JAMES A VYGR Common Stock P - Purchase D 19,3900 3.000 58 76.588
2018-08-21 2018-08-17 4 GERAGHTY JAMES A VYGR Common Stock P - Purchase D 18,3100 3.000 55 73.588
2018-07-18 2018-07-16 4 Turenne Andre VYGR Stock Option (Right to Buy) A - Award D 18,03 650.000 650.000
2018-06-21 2018-06-20 4 LEVIN MARK J VYGR Common Stock J - Other I -1.500.000 7.891.176
2018-06-21 2018-06-20 4 Third Rock Ventures III, L.P. VYGR Common Stock J - Other D -1.500.000 7.891.176
2018-06-18 2018-06-14 4 GERAGHTY JAMES A VYGR Stock Option (Right to Buy) A - Award D 21,64 15.000 15.000
2018-06-18 2018-06-14 4 DIXON WENDY L VYGR Stock Option (Right to Buy) A - Award D 21,64 15.000 15.000
2018-06-18 2018-06-14 4 Hyman Steven VYGR Stock Option (Right to Buy) A - Award D 21,64 15.000 15.000
2018-06-18 2018-06-14 4 LEVIN MARK J VYGR Stock Option (Right to Buy) A - Award D 21,64 15.000 15.000
2018-06-18 2018-06-14 4 Higgins Michael J VYGR Stock Option (Right to Buy) A - Award D 21,64 15.000 15.000
2018-06-18 2018-06-14 4 PIERCE GLENN VYGR Stock Option (Right to Buy) A - Award D 21,64 15.000 15.000
2018-06-18 2018-06-14 4 KARSEN PERRY A VYGR Stock Option (Right to Buy) A - Award D 21,64 15.000 15.000
2018-04-12 2018-04-10 4 Ravina Bernard VYGR Common Stock S - Sale D 18,3800 -2.451 -45 0
2018-03-26 2018-03-23 4 Henderson Jane VYGR Stock Option (Right to Buy) M - Exercise D 11,97 -11.200 165.584
2018-03-26 2018-03-23 4 Henderson Jane VYGR Common Stock S - Sale D 20,5200 -11.200 -230 0
2018-03-26 2018-03-23 4 Henderson Jane VYGR Common Stock M - Exercise D 11,9700 11.200 134 11.200
2018-03-26 2018-03-22 4 Henderson Jane VYGR Stock Option (Right to Buy) M - Exercise D 11,97 -19.900 176.784
2018-03-26 2018-03-22 4 Henderson Jane VYGR Common Stock S - Sale D 21,0700 -19.900 -419 0
2018-03-26 2018-03-22 4 Henderson Jane VYGR Common Stock M - Exercise D 11,9700 19.900 238 19.900
2018-03-20 2018-03-19 4 Henderson Jane VYGR Stock Option (Right to Buy) M - Exercise D 11,97 -1.900 196.684
2018-03-20 2018-03-19 4 Henderson Jane VYGR Common Stock S - Sale D 21,7600 -1.900 -41 0
2018-03-20 2018-03-19 4 Henderson Jane VYGR Common Stock M - Exercise D 11,9700 1.900 23 1.900
2018-03-20 2018-03-16 4 Henderson Jane VYGR Stock Option (Right to Buy) M - Exercise D 11,97 -15.416 198.584
2018-03-20 2018-03-16 4 Henderson Jane VYGR Common Stock S - Sale D 22,1500 -15.416 -341 0
2018-03-20 2018-03-16 4 Henderson Jane VYGR Common Stock M - Exercise D 11,9700 15.416 185 15.416
2018-03-14 2018-03-12 4 Ravina Bernard VYGR Common Stock S - Sale D 25,1600 -2.451 -62 2.451
2018-03-09 2018-03-07 4 Henderson Jane VYGR Stock Option (Right to Buy) A - Award D 28,72 65.000 65.000
2018-03-09 2018-03-07 4 Ravina Bernard VYGR Stock Option (Right to Buy) A - Award D 28,72 65.000 65.000
2018-03-09 2018-03-07 4 Sah Dinah Ph.D. VYGR Stock Option (Right to Buy) A - Award D 28,72 65.000 65.000
2018-03-09 2018-03-07 4 Ottmer Matthew P. VYGR Stock Option (Right to Buy) A - Award D 28,72 65.000 65.000
2018-03-09 2018-03-07 4 PAUL STEVEN M VYGR Stock Option (Right to Buy) A - Award D 28,72 110.000 110.000
2018-03-01 2018-02-27 4 Sah Dinah Ph.D. VYGR Stock Option (Right to Buy) M - Exercise D 11,83 -4.063 60.937
2018-03-01 2018-02-27 4 Sah Dinah Ph.D. VYGR Stock Option (Right to Buy) M - Exercise D 11,09 -5.000 35.000
2018-03-01 2018-02-27 4 Sah Dinah Ph.D. VYGR Stock Option (Right to Buy) M - Exercise D 8,33 -4.376 28.570
2018-03-01 2018-02-27 4 Sah Dinah Ph.D. VYGR Stock Option (Right to Buy) M - Exercise D 7,27 -2.184 12.957
2018-03-01 2018-02-27 4 Sah Dinah Ph.D. VYGR Common Stock S - Sale D 30,0000 -15.623 -469 138.688
2018-03-01 2018-02-27 4 Sah Dinah Ph.D. VYGR Common Stock M - Exercise D 11,8300 -4.063 -48 154.311
2018-03-01 2018-02-27 4 Sah Dinah Ph.D. VYGR Common Stock M - Exercise D 11,0900 -5.000 -55 150.248
2018-03-01 2018-02-27 4 Sah Dinah Ph.D. VYGR Common Stock M - Exercise D 8,3300 -4.376 -36 145.248
2018-03-01 2018-02-27 4 Sah Dinah Ph.D. VYGR Common Stock M - Exercise D 7,2700 -2.184 -16 140.872
2018-02-13 2018-02-12 4 Ravina Bernard VYGR Common Stock S - Sale D 18,2400 -2.451 -45 4.902
2018-01-12 2018-01-10 4 Ravina Bernard VYGR Common Stock S - Sale D 16,4000 -3.630 -60 7.353
2017-12-13 2017-12-11 4 Ravina Bernard VYGR Common Stock S - Sale D 13,6300 -5.490 -75 10.983
2017-11-13 2017-11-10 4 Ravina Bernard VYGR Common Stock S - Sale D 13,2600 -5.490 -73 16.473
2017-10-12 2017-10-10 4 Ravina Bernard VYGR Common Stock S - Sale D 20,3300 -10.980 -223 21.963
2017-09-18 2017-09-14 4 Ottmer Matthew P. VYGR Stock Option (Right to Buy) A - Award D 15,87 250.000 250.000
2017-09-13 2017-09-11 4 Ravina Bernard VYGR Common Stock S - Sale D 14,3000 -10.980 -157 32.943
2017-09-13 2017-07-20 4 Ravina Bernard VYGR Common Stock S - Sale D 10,0000 -5.490 -55 49.413
2017-09-06 2017-09-05 4 Ravina Bernard VYGR Common Stock S - Sale D 10,0000 -5.490 -55 17.157
2017-07-07 3 Ravina Bernard VYGR Common Stock D 235.294
2017-07-07 3 Ravina Bernard VYGR Common Stock D 235.294
2017-07-07 3 Sah Dinah Ph.D. VYGR Common Stock D 277.376
2017-07-07 3 Sah Dinah Ph.D. VYGR Common Stock D 277.376
2017-06-30 2017-06-29 4 Higgins Michael J VYGR Stock Option (Right to Buy) A - Award D 9,06 15.000 15.000
2017-06-30 2017-06-29 4 DIXON WENDY L VYGR Stock Option (Right to Buy) A - Award D 9,06 15.000 15.000
2017-06-30 2017-06-29 4 LEVIN MARK J VYGR Stock Option (Right to Buy) A - Award D 9,06 15.000 15.000
2017-06-30 2017-06-29 4 PIERCE GLENN VYGR Stock Option (Right to Buy) A - Award D 9,06 15.000 15.000
2017-06-30 2017-06-29 4 KARSEN PERRY A VYGR Stock Option (Right to Buy) A - Award D 9,06 15.000 15.000
2017-06-30 2017-06-29 4 Hyman Steven VYGR Stock Option (Right to Buy) A - Award D 9,06 15.000 15.000
2017-06-30 2017-06-29 4 GERAGHTY JAMES A VYGR Stock Option (Right to Buy) A - Award D 9,06 15.000 15.000
2017-04-14 2017-04-12 4 LEVIN MARK J VYGR Common Stock J - Other I -920.000 9.391.176
2017-04-14 2017-04-12 4 Third Rock Ventures III, L.P. VYGR Common Stock J - Other D -920.000 9.391.176
2017-02-10 2017-02-08 4 PAUL STEVEN M VYGR Stock Option (Right to Buy) A - Award D 11,83 11,8300 240.000 2.839 240.000
2017-01-05 2017-01-03 4 DIXON WENDY L VYGR Stock Option (Right to Buy) A - Award D 11,97 30.000 30.000
2017-01-05 2017-01-03 4 PIERCE GLENN VYGR Stock Option (Right to Buy) A - Award D 11,97 30.000 30.000
2017-01-05 2017-01-03 4 Henderson Jane VYGR Stock Option (Right to Buy) A - Award D 11,97 214.000 214.000
2016-12-21 2016-12-19 4 Third Rock Ventures III, L.P. VYGR Common Stock J - Other D -750.000 10.311.176
2016-12-21 2016-12-19 4 LEVIN MARK J VYGR Common Stock J - Other D -750.000 10.311.176
2016-06-20 2016-06-15 4 Higgins Michael J VYGR Stock Option (Right to Buy) A - Award D 13,70 15.000 15.000
2016-06-17 2016-06-15 4 KARSEN PERRY A VYGR Stock Option (Right to Buy) A - Award D 13,70 15.000 15.000
2016-06-17 2016-06-15 4 LEVIN MARK J VYGR Stock Option (Right to Buy) A - Award D 13,70 15.000 15.000
2016-06-17 2016-06-15 4 GERAGHTY JAMES A VYGR Stock Option (Right to Buy) A - Award D 13,70 15.000 15.000
2016-06-17 2016-06-15 4 Hyman Steven VYGR Stock Option (Right to Buy) A - Award D 13,70 15.000 15.000
2016-02-02 2016-02-01 4 Goater Jeff VYGR Stock Options (Right to Buy) A - Award D 11,09 11,0900 25.000 277 65.000
2016-02-02 2016-02-01 4 Goater Jeff VYGR Stock Options (Right to Buy) A - Award D 11,09 11,0900 40.000 444 40.000
2016-02-02 2016-02-01 4 PAUL STEVEN M VYGR Stock Options (Right to Buy) A - Award D 11,09 11,0900 200.000 2.218 200.000
2016-01-15 2016-01-14 4 PAUL STEVEN M VYGR Common Stock P - Purchase D 14,0690 10.000 141 872.351
2015-11-18 2015-11-16 4 Hadley Harbor Master Investors (Cayman) L.P. VYGR Series B Convertible Preferred Stock C - Conversion D -2.000.000 0
2015-11-18 2015-11-16 4 Hadley Harbor Master Investors (Cayman) L.P. VYGR Common Stock C - Conversion D 470.588 470.588
2015-11-18 2015-11-16 4 Third Rock Ventures III, L.P. VYGR Series A Preferred Stock C - Conversion D -45.000.000 0
2015-11-18 2015-11-16 4 Third Rock Ventures III, L.P. VYGR Common Stock C - Conversion D 10.588.235 11.061.176
2015-11-18 2015-11-16 4 LEVIN MARK J VYGR Series A Preferred Stock C - Conversion I -45.000.000 0
2015-11-18 2015-11-16 4 LEVIN MARK J VYGR Common Stock C - Conversion I 10.588.235 11.061.176
2015-11-18 2015-11-16 4 Sanofi Via wholly owned subsidiary Aventis Inc. VYGR Common stock Par value per share $ 0.001 P - Purchase I 14,0000 125.000 1.750 2.477.941
2015-11-18 2015-11-10 4 Sanofi Via wholly owned subsidiary Aventis Inc VYGR Shares of Series B convertible preferred stock C - Conversion I 0,00 -10.000.000 0
2015-11-18 2015-11-10 4 Sanofi Via wholly owned subsidiary Aventis Inc. VYGR Common stock Par value per share $ 0.001 C - Conversion I 2.352.941 2.352.941
2015-11-10 3 PAUL STEVEN M VYGR Common Stock D 1.724.702
2015-11-10 3 PAUL STEVEN M VYGR Common Stock D 1.724.702
2015-11-10 3 GERAGHTY JAMES A VYGR Common Stock D 141.176
2015-11-10 3 GERAGHTY JAMES A VYGR Common Stock D 141.176
2015-11-10 3 LEVIN MARK J VYGR Common Stock I 945.882
2015-11-10 3 LEVIN MARK J VYGR Common Stock I 945.882
2015-11-10 3 Hadley Harbor Master Investors (Cayman) L.P. VYGR No securities are benefically owned D 0
2015-11-10 3 TEPPER ROBERT I VYGR Common Stock D 945.882
2015-11-10 3 TEPPER ROBERT I VYGR Common Stock D 945.882
2015-11-10 3 TEPPER ROBERT I VYGR Common Stock D 945.882
2015-11-10 3 TEPPER ROBERT I VYGR Common Stock D 945.882
2015-11-10 3 TEPPER ROBERT I VYGR Common Stock D 945.882
2015-11-10 3 TEPPER ROBERT I VYGR Common Stock D 945.882
2015-11-10 3 Goater Jeff VYGR Common Stock D 129.410
2015-11-10 3 Goater Jeff VYGR Common Stock D 129.410
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Other Listings
DE:VT6 3,26 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista